Article
The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
Alimentary pharmacology & therapeutics - 1 Mar 2017
Conway G, Velonias G, Andrews E, Garber J J, Yajnik V, Ananthakrishnan A N
Abstract excerpt
BACKGROUND: Inflammatory bowel diseases lead to progressive bowel damage and need for surgery. While the increase in prevalence of other immune-mediated diseases in IBD is well recognised, the impact of this on the natural history of IBD is unknown. AIM: To determine the impact of concomitant immune-mediated diseases on phenotypes and outcomes in IBD. METHODS: Patients with IBD enrolled in a prospective registry...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
